Name | amyloid P-IN-1 |
---|
Description | pharmaceutical compositions comprising the same and the use of the same for treatment of diseases or disorders wherein depletion of serum amyloid P component (SAP) would be beneficial, including amyloidosis, Alzheimer's disease, type 2 diabetes mellitus and osteoarthritis. |
---|---|
Related Catalog | |
References |
[1]. PCT Int. Appl. (2015), WO 2015165833 A1 20151105. [2]. U.S. Pat. Appl. Publ. (2016), US 20160081983 A1 20160324. |
Molecular Formula | C30H44N2O14 |
---|---|
Molecular Weight | 656.68 |
Storage condition | 2-8℃ |